top of page

Selected Publications

Research and Review Articles:

​

#Corresponding authors
*Contributed equally

​

2024

  • Wong BP*, Chan CY*, Xue HD*, Goh CC, Cheu JW, Tse AP, Zhang MS, Zhang Y, Wong CC. Cell cycle inhibitors activate hypoxia-induced DDX41-STING pathway to mediate anti-tumor immune response in liver cancer. JCI Insight. 2024 Oct 10:e170532. doi: 10.1172/jci.insight.170532. Epub ahead of print. PMID: 39388278.

  • Cheu JW, Wong CC. The immune microenvironment of steatotic hepatocellular carcinoma: Current findings and future prospects. Hepatology Communications. 2024 Sep 8(9):e0516. DOI: 10.1097/HC9.0000000000000516

  • Chen Y, Wong CC. The Mechanistic Insights Behind the Anti-Cancer Effects of Statins in Liver Cancer. Hepatology Communications. 2024 Sep 8(9):e0519. DOI: 10.1097/HC9.0000000000000519

  • Wong CC, Tapper EB, Malhi H, Gores GJ. Manuscript best practices. Takeaways from a community conversation. Hepatology. 2-24 Jun 1;79 (6)1243-1245.  doi: 10.1097/HEP.0000000000000849. 

  • Chan FF, Yuen VW, Shen J, Chin DW, Law CT, Wong BP, Chan CY, Cheu JW, Ng IO, Wong CC, Wong CM. Inhibition of CAF-1 histone chaperone complex triggers cytosolic DNA and dsRNA sensing pathways and induces intrinsic immunity of hepatocellular carcinoma. Hepatology. 2024 Aug 1;80(2):295-311. doi: 10.1097/HEP.0000000000000709. Epub 2023 Dec 5.

​

2023​​

  • Fuchs E, Sahai E, Weeraratna AT, Deneen B, Wong CC, Simon A. Understanding the microenvironment and how this controls cell fate. Dev Cell. 2023 Dec 18;58(24):2819-2821. doi: 10.1016/j.devcel.2023.11.025. 

  • Malhi H, Brown RS Jr, Lim JK, Reau N, Tapper EB, Wong CC, Gores GJ. Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journals. Hepatology. 2023 Dec 1;78(6):1680-1681. doi: 10.1097/HEP.0000000000000619. Epub 2023 Nov 9.

  • Malhi H, Brown RS Jr, Lim JK, Reau N, Tapper EB, Wong CC, Gores GJ. Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journals. Hepatology Communications. 2023 Nov 9;7(11):e0318. doi: 10.1097/HC9.0000000000000318. eCollection 2023 Nov 1.

  • Malhi H, Brown RS Jr, Lim JK, Reau N, Tapper EB, Wong CC, Gores GJ. Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journals. Liver Transpl. 2023 Dec 1;29(12):1262-1263. doi: 10.1097/LVT.0000000000000279. Epub 2023 Nov 9.

  • Man CH, Lam W, Dang CC, Zeng XY, Zheng LC, Chan NN, Ng KL, Chan KC, Kwok TH, Ng TC, Leung WY, Huen MS, Wong CC, So CWE, Dou Z, Goyama S, Bray MR, Mak TW, Leung AY. Inhibition of PLK4 remodels histone methylation and activates the immune response via the cGAS-STING pathway in TP53-mutated AML. Blood. 2023 Dec 7;142(23):2002-2015. doi: 10.1182/blood.2023019782.

  • Cheu JW, Chiu DK, Kwan KK, Yang C, Yuen VW, Goh CC, Chui NN, Shen W, Law CT, Li Q, Zhang MS, Bao MH, Wong BP, Chan CY, Liu CX, Sit GF, Ooi ZY, Deng H, Tse AP, Ng IO, Wong CC#. Hypoxia-inducible factor orchestrates adenosine metabolism to promote liver cancer development. Sci Adv. 2023 May 5;9(18):eade5111. doi: 10.1126/sciadv.ade5111

  • Tapper EB, Wong CC.  The future of Hepatology Communications. Hepatology Communications. 2023 Mar 17;7(4):e0085. doi: 10.1097/HC9.0000000000000085. eCollection 2023 Apr 1.

  • Cheu JW*, Lee D*, Li Q*, Goh CC, Bao MH, Yuen VW, Zhang MS, Yang C, Chan CY, Tse AP, Sit GF, Liu CX, Ng IO, Wong CM, Wong CC#. Ferroptosis suppressor protein 1 inhibition promotes tumor ferroptosis and anti-tumor immune responses in liver cancer. Cell Mol Gastroenterol Hepatol. 2023 Mar 7:S2352-345X(23)00038-3. doi: 10.1016/j.jcmgh.2023.03.001.

  • Chan CY, Yuen VW, Chiu DK, Goh CC, Thu K, Cescon DW, Soria-Bretones I, Law CT, Cheu JW, Lee D, Tse AP, Tan KV, Zhang MS, Wong BP, Wong CM, Khong PL, Ng IO, Bray MR, Mak TW, Yau TC#, Wong CC#. PLK4 inhibitor, CFI-400945, suppresses liver cancer through cell cycle perturbation and eliciting anti-tumor immunity. Hepatology. Hepatology. 2023 Mar 1;77(3):729-744. doi: 10.1002/hep.32461.

  • Yuen VW*, Chiu DK*, Law CT*, Cheu JW, Chan CY, Wong BP, Goh CC, Zhang MS, Xue HD, Tse AP, Zhang Y, Lau HY, Lee D, Au Yeung RK, Wong CM, Wong CC#. Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responses.  J Hepatol. 2023 Feb;78(2):376-389. doi: 10.1016/j.jhep.2022.10.037.

​

2022​​

  • Yang C, Lee D, Zhang MS, Tse AP, Wei L, Bao MH, Wong BP, Chan CY, Yuen VW, Chen Y, Wong CC#. Genome-wide CRISPR/Cas9 library screening revealed dietary restriction of glutamine in combination with inhibition of pyruvate metabolism as effective liver cancer treatment. Advanced Science. 2022 Dec;9(34):e2202104. doi: 10.1002/advs.202202104

  • Tan GH, Wong CC#. Role of Metabolism in Adoptive T Cell Therapy: Strategies and Challenges. Antioxidants & Redox Signaling. 2022 Dec;37(16-18):1303-1324. doi: 10.1089/ars.2022.0037. (Review)

  • Chan CY, Chiu DK, Yuen VW, Law CT, Wong BP, Thu KL, Cescon DW, Soria-Bretones I, Cheu JW, Lee D, Tse AP, Zhang MS, Tan KV, Ng IO, Khong PL, Yau TC, Bray MR, Mak TW#, Wong CC#. CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma. Proceedings of National Academy of Sciences. 2022 Aug 9;119(32):e2119514119. doi: 10.1073/pnas.2119514119.

  • Husain A*, Chiu YT*, Sze KM, Ho DW, Tsui YM, Suarez EMS, Zhang VX, Chan LK, Lee E, Lee JM, Cheung TT, Wong CC, Chung CY, Ng IO. Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma. J Hepatol. 2022 Aug;77(2):383-396. doi: 10.1016/j.jhep.2022.02.018.

  • Zhang MS, Cui JD, Lee D, Yuen VW, Chiu DK, Goh C, Cheu JW, Tse AP, Bao MH, Wong BP, Chen CY, Wong CM, Ng IO, Wong CC#. Hypoxia-induced macropinocytosis represents a metabolic route for liver cancer. Nature Communications. 2022 Feb 17;13(1):954.

  • Shen J, Yang C, Zhang MS, Chin DW, Chan FF, Law CT, Wang G, Cheng CL, Chen M, Wan RT, Lee TK, Ng IO, Wong CC#, Wong CM#. Histone chaperone FACT complex coordinates with HIF to mediate an expeditious transcription program to adapt to poorly oxygenated cancers. Cell Reports. 2022 Feb 1;38(5):110304. doi: 10.1016/j.celrep.2022.110304.

  • Chui NN*, Cheu JW*, Yuen VW, Chiu DK, Goh CC, Lee D, Zhang MS, Ng IO, Wong CC#. Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell–Mediated Antitumor Immunity Through PD-L1. Hepatology Communications. 2022 Jan;6(1):178-193.

 

2021

  • Zhang VX, Sze KM, Chan LK, Ho DW, Tsui YM, Chiu YT, Lee E, Husain A, Huang HY, Tian L, Wong CC, Ng IO. Antioxidant supplements promote tumor formation and growth and confer drug resistance in hepatocellular carcinoma by reducing intracellular ROS and induction of TMBIM1. Cell Biosci. 2021 Dec 19;11(1):217.

  • Cable J, Pei DQ, Reid LM, Wang XW, Bhatia S, Karras P, Melenhorst JJ, Grompe M, Lathia JD, Song E, Kuo CJ, Zhang N, White RM, Ma SK, Ma LC, Chin YR, Shen MM, Ng IO, Kaestner KH, Zhou L, Sikandar S, Schmitt CA, Guo W, Wong CC, Ji JF, Tang DG, Dubrovska A, Yang CZ, Wiedemeyer WR, Weissman IL. Cancer stem cells: advances in biology and clinical translation-a Keystone Symposia report. Ann N Y Acad Sci. 2021 Dec;1506(1):142-163. (Review)

  • Cheng CL, Tsang FH, Wei L, Chen MN, Chin DW, Shen JL, Law CT, Lee D, Wong CC, Ng IO, Wong CM. Bromodomain-containing protein BRPF1 is a therapeutic target for liver cancer. Commun Biol. 2021 Jul 20;4(1):888.

  • Bao MH, Wong CC#. Hypoxia, metabolic reprogramming, and drug resistance in liver cancer. Cells. 2021 June 06;10(7):1715. (Review)

  • Ho DW, Tsui YM, Chan LK, Sze KM, Zhang X, Cheu JW, Chiu YT, Lee JM, Chan AC, Cheung ET, Yau DT, Chia NH, Lo IL, Sham PC, Cheung TT, Wong CC, Ng IO. Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma. Nature Communications. 2021 June 17;12(1):3684.

  • Cheu JW, Wong CC#. Mechanistic rationales guiding combination hepatocellular carcinoma therapies involving immune checkpoint inhibitors. Hepatology. 2021 Apr 3. doi: 10.1002/hep.31840. (Review)

  • Lee D*, Zhang MS*, Tsang FH, Bao MH, Xu IM, Lai RK, Chiu DK, Tse AP, Law DC, Chan CY, Yuen VW, Chui NN, Ng IO, Wong CM, Wong CC#. Adaptive and constitutive activations of malic enzymes confer liver cancer multi-layered protection against ROS. Hepatology. 2021 Aug;74(2): 776-796. 

  • Bao MH*, Yang C*, Tse AP*, Wei LL*, Lee D*, Zhang MS, Goh CC, Chiu DK, Yuen VW, Law DC, Chin W, Chui NN, Wong BP, Chan CY, Ng IO, Chung CY, Wong CM#, Wong CC#. Genome-wide CRISPR-Cas9 knockout library screening identified PTPMT1 in cardiolipin synthesis is crucial to survival in hypoxia in hepatocarcinoma. Cell Reports. 2021 Jan;34(4):108676.

  • Chan LK, Ho DW, Kam CS, Chiu EY, Lo IL, Yau DT, Cheung ET, Tang CN, Tang VW, Lee TK, Wong CC, Chok KS, Chan AC, Cheung TT, Wong CM, Ng IO. RSK2-inactivating mutations potentiate MAPK signaling and support cholesterol metabolism in hepatocellular carcinoma. Journal of Hepatology. 2021 Feb;74(2):360-371.

​

2020

  • Yuen VW, Wong CC#. Hypoxia-inducible factors and innate immunity in liver cancer. J Clin Invest. 2020 Oct 1;130(10):5052-5062. doi: 10.1172/JCI137553 (Review)

  • Leung MS, Chan KK, Dai WJ, Wong CY, Au KY, Wong PY, Wong CC, Lee TK, Ng IO, Kao WJ, Lo RC. Anti-tumour effects of PIM kinase inhibition on progression and chemoresistance of hepatocellular carcinoma. J Pathol. 2020 Sep;252(1):65-76. doi: 10.1002/path.5492

  • Chiu DK*, Yuen VW*, Cheu JW, Wei L, Ting V, Fehlings M, Sumatoh H, Nardin A, Newell EW, Ng IO, Yau TC, Wong CM, Wong CC#. Hepatocellular carcinoma cells upregulate PVRL1, stabilizing PVR and inhibiting the cytotoxic T-cell response via TIGIT to mediate tumor resistance to PD1 inhibitors in mice. Gastroenterology. 2020 Aug;159(2):609-623. doi: 10.1053/j.gastro.2020.03.074​

    • Featured by editorial commentary in Gastroenterology.

      • Peng H and Fu Y. The Inhibitory PVRL1/PVR/TIGIT Axis in Immune Therapy for Hepatocellular Carcinoma. Gastroenterology. 2020 Aug;159(2):434-436.doi: 10.1053/j.gastro.2020.06.024

  • Shen J, Chen M, Lee D, Law CT, Wei L, Tsang FH, Chin DW, Cheng CL, Lee JM, Ng IO, Wong CC#, Wong CM#. Histone chaperone FACT complex mediates oxidative stress response to promote liver cancer progression. Gut. 2020 Feb; 69 (2): 329-342. doi: 10.1136/gutjnl-2019-318668

    • Featured by editorial commentary in Gut.

      • Foglia B, Parola M. Of FACT complex and oxidative stress response: a KEAP1/NRF2-dependent novel mechanism sustaining hepatocellular carcinoma progression. Gut. 2020 Feb;69(2):195-196. doi: 10.1136/gutjnl-2019-319609

​

2019

  • Chiu DK*, Tse AP*, Law CT, Xu IM, Lee D, Chen M, Lai RK, Yuen VW, Cheu JW, Ho DW, Wong CM, Zhang H, Ng IO#, Wong CC#. Hypoxia regulates the mitochondrial activity of hepatocellular carcinoma cells through HIF/HEY1/PINK1 pathway. Cell Death & Disease. 2019 Dec 9;10(12):934.​ doi: 10.1038/s41419-019-2155-3

  • Wei L, Lee D, Law CT, Zhang MS, Shen J, Chin DW, Zhang A, Tsang FH, Wong CL, Ng IO, Wong CC#, Wong CM#. Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC. Nat Commun. 2019 Oct 15;10(1):4681. ​doi: 10.1038/s41467-019-12606-7

  • Tsang FH, Law CT, Tang TC, Cheng CL, Chin DW, Tam WV, Wei L, Wong CC, Ng IO#, Wong CM#. Aberrant super-enhancer landscape in human hepatocellular carcinoma. Hepatology. 2019 Jun;69(6):2502-2517. doi: 10.1002/hep.30544

  • Chen F, Zhou J, Li Y, Zhao Y, Yuan J, Cao Y, Wnag L, Zhang Z, Zhang B, Wang CC, Cheung TH, Wu Z, Wong CC, Sun H#, Wang H#. YY1 regulates skeletal muscle regeneration through controlling metabolic reprogramming of satellite cells. EMBO J. 2019 May 15;38(10):e99727. doi: 10.15252/embj.201899727

  • Lee D, Xu IM, Chiu DK, Leibold J, Tse AP, Bao MH, Yuen VW, Chan CY, Lai RK, Chin DW, Chan DF, Cheung TT, Chok SH, Wong CM, Lowe SW, Ng IO#, Wong CC#. Induction of oxidative stress through inhibition of thioredoxin reductase 1 is an effective therapeutic approach for hepatocellular carcinoma. Hepatology. 2019 Apr;69(4):1768-1786. doi: 10.1002/hep.30467

  • Law CT, Wei L, Tsang FH, Chan CY, Xu IM, Lai RK, Ho DW, Lee JM, Wong CC, Ng IO#, Wong CM#. HELLS regulates chromatin remodeling and epigenetic silencing of multiple tumor suppressor genes in human hepatocellular carcinoma. Hepatology. 2019 May;69(5):2013-2030. doi: 10.1002/hep.30414

 

2018

  • Tse AP, Sze KM, Shea QT, Chiu EY, Tsang FH, Chiu DK, Zhang MS, Lee D, Xu IM, Chan CY, Koh H, Wong CM, Zheng YP, Ng IO#, Wong CC#. Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer. Oncogenesis. 2018 May 25;7(5):44 doi: 10.1038/s41389-018-0052-8

​

2017

  • Chen M, Wei L, Law CT, Tsang FH, Shen J, Cheng CL, Tsang LH, Ho DW, Chiu DK, Lee JM, Wong CC, Ng IO#, Wong CM#. RNA N6-methyladenosine methyltransferase METTL3 promotes liver cancer progression through YTHDF2 dependent post-transcriptional silencing of SOCS2. Hepatology. 2018 Jun;67(6):2254-2270. doi: 10.1002/hep.29683

  • Chiu DK, Tse AP, Xu IM, Cui JD, Lai RK, Li LL, Koh H, Tsang FH, Wei LL, Wong CM, Ng IO#, Wong CC#. Hypoxia inducible factor-1 (HIF-1) promotes myeloid-derived suppressor cell (MDSC) accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma­­­­. Nat Commun. 2017 Sep 11;8(1):517. doi: 10.1038/s41467-017-00530-7

  • Wei L, Chiu DK, Tsang FH, Law DC, Cheng CL, Au SL, Lee JM, Wong CC, Ng IO#, Wong CM#. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3. J Hepatol. 2017 Oct;67(4):758-769. doi: 10.1016/j.jhep.2017.05.015

  • Lee D*, Xu IM*, Chiu DK*, Lai RK, Tse AP, Li LL, Law CT, Tsang FH, Wei LL, Chan CY, Wong CM, Ng IO#, Wong CC#. Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma. J Clin Invest. 2017 May 1;127(5):1856-1872. doi: 10.1172/JCI90253

    • Invited Commentary

      • Lee D, Wong CC. Lee D, Wong CC. The folate cycle is a new metabolic weakness of cancer. Mol Cell Oncol. 2017 May 19;4(6):e1327004. doi: 10.1080/23723556.2017.1327004

  • Cui CP, Wong CC, Kai AK, Ho DW, Lau EY, Tsui YM, Chan LK, Cheung TT, Chok KS, Chan AC, Lo RC, Lee JM, Lee TK, Ng IO#. SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop. Gut. 2017 Dec;66(12):2149-2159. doi: 10.1136/gutjnl-2016-313264

​​

2016

  • Chiu DK, Xu IM, Lai RK, Tse AP, Wei LL, Koh H, Li LL, Lee D, Lo RC, Wong CM, Ng IO#, Wong CC#. Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) Ligand 26. Hepatology 64(3):p 797-813, September 2016. doi: 10.1002/hep.28655

  • Kai AK, Chan LK, Lo RC, Lee JM, Wong CC, Wong CM, Ng IO#. Down-regulation of TIMP2 by HIF-1α/miR-210/HIF-3α regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma. Hepatology 64(2):p 473-487, August 2016. doi: 10.1002/hep.28577

  • Ma W, Sze KM, Chan LK, Lee JM, Wei LL, Wong CM, Lee TK, Wong CC, Ng IO#. RhoE/ROCK2 regulates chemoresistance through NFκB/IL-6/STAT3 signaling in hepatocellular carcinoma. Oncotarget. 2016 Jul 5;7(27):41445-41459. doi: 10.18632/oncotarget.9441

  • Lai RK, Xu IM, Chiu DK, Tse AP, Wei LL, Law CT, Lee D, Wong CM, Wong MP, Ng IO#, Wong CC#. NDUFA4L2 fine-tunes oxidative stress in hepatocellular carcinoma. Clinical Cancer Research. 2016 Jun 15;22(12):3105-17. doi: 10.1158/1078-0432.CCR-15-1987.

  • Wong CM#*, Wei L, Law CT, Ho DW, Tsang FH, Au SL, Sze KM, Lee JM, Wong CC, Ng IO#. Up-regulation of histone methyltranserase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis. Hepatology 63(2):p 474-487, February 2016. doi:10.1002/hep.28304

  • Xu IM, Lai RK, Lin SH, Tse AP, Chiu DK, Koh H, Law CT, Wong CM, Cai Z, Wong CC#, Ng IO#. Transketolase counteracts oxidative stress to drive cancer development. Proceedings of National Academy of Sciences. 2016 Feb 9;113(6):E725-34. doi: 10.1073/pnas.1508779113

 

2015

  • Wong CM#*, Wei L, Au SL, Fan DN, Zhou Y, Tsang FH, Law CT, Lee JM, He X, Shi J, Wong CC, Ng IO#. MiR-200b/200c/429 subfmaily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis. Oncotarget. 2015 May 30;6(15):13658-70. doi: 10.18632/oncotarget.3700.

  • Leung CO, Wong CC, Fan DN, Kai AK, Tung EK, Xu IM, Ng IO#, Lo RC#. PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma. Oncotarget. 2015 May 10;6(13):10880-92. doi: 10.18632/oncotarget.3534.

  • Tsang FH, Au SL, Wei L, Fan DN, Lee JM, Wong CC, Ng IO#, Wong CM#. Long non-coding RNA HOTTIP is frequently up-regulated in hepatocellular carcinoma and is targeted by tumor suppressive miR-125b. Liver International. 2015 May;35(5):1597-606. doi: 10.1111/liv.12746.

​

2014

  • Wong CC#*, Au SL*, Tse AP, Xu IM, Lai RK, Chiu DK, Wei LL, Fan DN, Tsang FH, Lo RC, Wong CM, Ng IO#. Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis. PLoS ONE. 2014 Dec 26;9(12):e115036. doi: 10.1371/journal.pone.0115036.

  • Wong CC#, Tse AP, Huang YP, Zhu YT, Chiu DK, Lai RK, Au SL, Kai AK, Lee JM, Wei LL, Tsang FH, Lo RC, Shi J, Zheng YP, Wong CM, Ng IO#. Lysyl Oxidase-Like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma. Hepatology. 2014 Nov;60(5):1645-58. doi: 10.1002/hep.27320.

  • Wong CC, Kai AK, Ng IO. The impact of hypoxia in hepatocellular carcinoma metastasis. Frontiers of Medicine. 2014 Mar;8(1):33-41. doi: 10.1007/s11684-013-0301-3.

 

2013

  • Au SL, Wong CC, Lee JM, Wong CM, Ng IO#. EZH2-mediated H3K27me3 involves in epigenetic repression of Deleted in liver cancer 1 in human cancers. PLoS ONE. 2013 Jun 27;8(6):e68226. doi: 10.1371/journal.pone.0068226.

  • Hubbi ME, Kshitiz, Gilkes DM, Rey S, Wong CC, Luo W, Kim D, Dang CV, Levchenko A, Semenza GL#. A non-transcriptional role of HIF-1α as a direct inhibitor of DNA replication. Science Signaling. 2013 Feb 12;6(262):ra10. doi: 10.1126/scisignal.2003417.

  • Fan DN, Tsang FH, Au SL, Wong CC, Wei LL, Lee JM, He X, Ng IO#, Wong CM#. SUV39H1 overexpression promotes HCC progression and is negatively regulated by microRNA-125b. Hepatology. 2013 Feb;57(2):637-47. doi: 10.1002/hep.26083.

  • Chaturvedi P, Gilkes DM, Wong CC, Kschitiz, Zhang H, Wei H, Takano N, Schito L, Levchenko A, Semenza GL. Hypoxia-inducible factors promote metastasis by mediating bidirectional signaling between breast cancer cells and mesenchymal stem cells. Journal of Clinical Investigation. 2013 Jan;123(1):189-205. doi: 10.1172/JCI64993.

 

2012

  • Schito L, Rey S, Tafani M, Zhang H, Wong CC, Russo A, Russo MA, Semenza GL. Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells. Proceedings of National Academy of Sciences. 2012 Sep 10;109(40):E2707-16. doi: 10.1073/pnas.1214019109

  • Ma W, Wong CC, Tung EK, Wong CM, Ng IO. RhoE is frequently down-regulated in hepatocellular carcinoma (HCC) and suppresses HCC invasion through antagonizing the Rho/Rho-Kinase/Myosin phosphatase target pathway. Hepatology. 2013 Jan;57(1):152-161. doi: 10.1002/hep.25987

  • Wong CC, Zhang H, Gilkes DM, Chen J, Wei H, Chaturvedi P, Hubbi M, Semenza GL. Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis. Journal of Molecular Medicine. 2012 Jul;90(7):803-15. doi: 10.1007/s00109-011-0855-y

  • Au SL, Wong CC, Lee JM, Fan DN, Tsang FH, Ng IO, Wong CM. Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis. Hepatology. 2012 Aug;56(2):622-31. doi: 10.1002/hep.25679

  • Wong CM*, Wong CC*, Lee JM, Fan DN, Au SL, Ng IO. Sequential alterations of microrna expression in hepatocellular carcinoma development and venous metastasis. Hepatology. 2012 May;55(5):1453-61. doi: 10.1002/hep.25512

 

2008-2011

  • Wong CC, Gilkes DG, Zhang H, Chen J, Wei H, Chaturvedi P, Fraley SI, Wong CM, Khoo US, Ng IO, Wirtz D, Semenza GL. Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation. Proceedings of National Academy of Sciences. 2011 Sep 12;108(39):16369-74. doi: 10.1073/pnas.1113483108

  • Gao P, Wong CC, Tung EK, Lee JM, Wong CM, Ng IO. Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis. Journal of Hepatology. 2011 Jun; 54 (6): 1177-1184. doi: 10.1016/j.jhep.2010.09.023

  • Wong CM, Wong CC, Ng YL, Au SL, Ko FC, Ng IO. Transcriptional repressive H3K9 and H3K27 methylations contribute to DNMT1-mediated DNA methylation recovery. PLoS ONE.  2011 Feb 8;6(2):e16702. doi: 10.1371/journal.pone.0016702

  • Wong CC*, Wong CM*, Tung EK, Au SL, Lee JM, Man K, Ng IO.  The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-Kinase 2. Gastroenterology. 2011 Jan;140(1):322-31. doi: 10.1053/j.gastro.2010.10.006 (Top 2% of published articles in biology and medicine, Faculty of 1000)

  • Wong CC, Wong CM, Au SL, Ng IO. RhoGTPases and Rho-effectors in hepatocellular carcinoma metastasis: ROCK N' Rho move it. Liver International. 2010 May;30(5):642-56. doi: 10.1111/j.1478-3231.2010.02232.x

  • Wong CC, Wong CM, Tung EK, Man K, Ng IO.  Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion. Hepatology. 2009 May;49(5):1583-94. doi: 10.1002/hep.22836 

  • Wong CC, Wong CM, Ko FC, Chan LK, Ching YP, Yam JW, Ng IO.  Deleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinoma.  PLoS ONE.  2008 July 23; 3(7): e2779. doi: 10.1371/journal.pone.0002779

  • Lung HL, Lo CC, Wong CC, Cheung AK, Cheong KF, Wong N, Kwong FM, Chan KC, Law EW, Tsao SW, Chua D, Sham JS, Cheng Y, Stanbridge EJ, Robertson GP, Lung ML. Identification of tumor suppressive activity by irradiation microcell-mediated chromosome transfer and involvement of alpha B-crystallin in nasopharyngeal carcinoma. International Journal of Cancer. 2008 Mar 15;122(6):1288-96. doi: 10.1002/ijc.23259

  • Wong CM, Ng YL, Lee JM, Wong CC, Cheung OF, Chan CY, Tung EK, Ching YP, Ng IO. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma. Hepatology. 2007 May;45(5):1129-38. doi: 10.1002/hep.21578
     

​

Book Chapters:

  • Chan CY*, Yuen VW,* Wong CC. Hypoxia and the metastatic niche. Adv Exp Med Biol. 2019;1136:97-112. doi: 10.1007/978-3-030-12734-3_7

  • Chiu DK*, Zhang MS*, Tse AP*, Wong CC. Assessment of stabilization and activity of the HIFs important for hypoxia-Induced signalling in cancer cells. Methods Mol Biol. 2019;1928:77-99. doi: 10.1007/978-1-4939-9027-6_6

bottom of page